Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Predictive factors associated with pemetrexed acute toxicity.
Eur J Clin Pharmacol. 2023 May;79(5):635-641. doi: 10.1007/s00228-023-03478-4. Epub 2023 Mar 23.
Eur J Clin Pharmacol. 2023.
PMID: 36951965
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study.
Boudou-Rouquette P, Arrondeau J, Gervais C, Durand JP, Fabre E, De Percin S, Villeminey CV, Piketty AC, Rassy N, Ulmann G, Damotte D, Mansuet-Lupo A, Giraud F, Alifano M, Wislez M, Alexandre J, Jouinot A, Goldwasser F.
Boudou-Rouquette P, et al. Among authors: villeminey cv.
EBioMedicine. 2021 Nov;73:103630. doi: 10.1016/j.ebiom.2021.103630. Epub 2021 Oct 20.
EBioMedicine. 2021.
PMID: 34688030
Free PMC article.
Item in Clipboard
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.
Bellesoeur A, Gataa I, Jouinot A, Mershati SE, Piketty AC, Tlemsani C, Balakirouchenane D, Monribot A, Vidal M, Batista R, de Percin S, Villeminey C, Alexandre J, Goldwasser F, Blanchet B, Boudou-Rouquette P, Thomas-Schoemann A.
Bellesoeur A, et al. Among authors: villeminey c.
Cancer Chemother Pharmacol. 2021 Oct;88(4):741-751. doi: 10.1007/s00280-021-04311-4. Epub 2021 Jul 24.
Cancer Chemother Pharmacol. 2021.
PMID: 34304283
Item in Clipboard
[Securing patients pathways treated by oral antitumoral: Guidelines for better organization of departments and management of incoming calls].
Fléchon A, Villeminey C, Despiau F, Bertrand C, Lecarpentier E, Joly F.
Fléchon A, et al. Among authors: villeminey c.
Bull Cancer. 2019 Jun;106(6):514-526. doi: 10.1016/j.bulcan.2019.03.015. Epub 2019 May 21.
Bull Cancer. 2019.
PMID: 31126678
French.
Item in Clipboard
[Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results].
Chabanol H, Huillard O, Prin L, Villeminey C, Rondeau A, Boudou-Rouquette P, Astorg F, Musenghesi B, Du Mortier C, Alexandre J, Goldwasser F.
Chabanol H, et al. Among authors: villeminey c.
Bull Cancer. 2018 Dec;105(12):1173-1182. doi: 10.1016/j.bulcan.2018.06.005. Epub 2018 Aug 2.
Bull Cancer. 2018.
PMID: 30078546
French.
Item in Clipboard
Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France.
Bonnet C, Boudou-Rouquette P, Azoulay-Rutman E, Huillard O, Golmard JL, Carton E, Noé G, Vidal M, Orvoen G, Chah Wakilian A, Villeminey C, Blanchet B, Alexandre J, Goldwasser F, Thomas-Schoemann A.
Bonnet C, et al. Among authors: villeminey c.
Cancer Chemother Pharmacol. 2017 May;79(5):1051-1055. doi: 10.1007/s00280-017-3291-z. Epub 2017 Mar 30.
Cancer Chemother Pharmacol. 2017.
PMID: 28361167
Item in Clipboard
Cite
Cite